# Intranasal Ketamine for Procedural Sedation

> **NCT02828566** · PHASE3 · UNKNOWN · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 470 (estimated)

## Conditions studied

- Bone Fractures
- Dislocations

## Interventions

- **DRUG:** IN ketamine
- **DRUG:** IV ketamine
- **DRUG:** IN saline 0.9%
- **DRUG:** IV saline 0.9%

## Key facts

- **NCT ID:** NCT02828566
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10
- **Primary completion:** 2019-01
- **Final completion:** 2019-02
- **Target enrollment:** 470 (ESTIMATED)
- **Last updated:** 2017-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02828566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02828566, "Intranasal Ketamine for Procedural Sedation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02828566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*